In the GDSC2 database analysis, high LIG1 expression in bladder cancer showed resistance to drugs such as ERK2440, Staurosporine, Nutlin-3a, Trametinib, ERK6604, Selumetinib, SCH772984, AZD1332, Dasatinib1079, Luminespib1669 and more. This evidence concerns the gene LIG1 and urinary bladder carcinoma.